Gender: Male
Date of birth: 05 February 1990
Residence: Bucharest, Romania
Short summary of skills, experience and career objective
Career objective:
To leverage a unique combination of strategic commercial leadership and advanced scientific expertise to drive innovation in the life sciences sector. As an agile-minded leader , I aim to bridge the gap between complex medical diagnostics and immunological mechanisms and patient-centric commercial strategies to improve healthcare outcomes in neurology and rare diseases.
Core Skills
Commercial Strategy & Execution: Expert in leading disease area strategies, brand life-cycle management, and market maturity assessment.
Scientific Expertise: PhD-level knowledge in pathobiology, virology, and vaccine development.
Stakeholder Engagement: Proven track record of fostering peer-to-peer relationships with Key Opinion Leaders (KOLs), clinicians, and international academic partners.
Agile Leadership: Experienced in the VACC leadership model, acting as an architect and catalyst within cross-functional squads.
Technical Proficiency: Skilled in BSL3 laboratory environments, clinical trial monitoring (GCP), and advanced data analysis
Professional profile
Career level:
Manager (Manager/Supervisor of Staff)
Medical specialty, field of interest:
Infectious Diseases, Microbiology, Veterinary virology
Research profile:
I am an accomplished researcher with a PhD in Pathobiology from Kansas State University and a history of managing vaccine development projects and multidisciplinary teams at prestigious institutions like The Pirbright Institute. My research profile is distinguished by high-level scientific communication and technical expertise in virology and molecular biology, evidenced by 20 ISI-indexed publications and numerous international presentations on emerging viral diseases.
Current (last) position held
Current employer company:
Roche
Bucharest, Romania
Job title:
Squad Lead
Duration:
01 July 2024 - 01 April 2026
Work experience
As the Squad Value Owner for Neurology at Roche, I am leading the disease area strategy and commercial execution for high medical value solutions by identifying ecosystem gaps and investment opportunities. Operating under a VACC leadership model, I\'m acting as a strategic architect to align cross-functional teams and external partners toward maximizing value within the patient journey.
Further work experience
I built a robust career through product management and senior research positions. At Roche, I am specialized in the commercial launch of Companion Diagnostics and Neurology brands by optimizing patient journeys and fostering cross-divisional collaboration. My first steps in the career was defined by high-impact scientific research at The Pirbright Institute and Kansas State University, where he led multidisciplinary teams in vaccine development, managed international industry partnerships, and published extensive findings in virology.
Education and Qualifications
2021
Post doctoral Researcher, working on vaccine development for African Swine Fever
Pirbright Institute
2019
PhD in Pathobiology
College of Veterinary Medicine at Kansas State University
2014
MSc in Biochemistry and Molecular Biology
University of Bucharest
2012
BSc in Biology
University of Bucharest
Language skills:
English: Native
Special skills:
BSL3 and SAPO4 certifications for working in high containment labs
Desired job profile
Desired job profile:
A research-driven professional with a PhD in Pathobiology and over a decade of experience in virology, immunology, and vaccine development. I am seeking a position that utilizes my deep technical expertise in emerging infectious diseases and molecular biology to lead clinical strategy, foster international scientific collaborations, and bridge the gap between bench research and high-value medical solutions.
Desired job title:
Virologist
Type of position:
Training position, Research position, ESCMID observership
Medical speciality:
Infectious Diseases
Type of contract:
Permanent, Temporary/contract/project
Job status:
Full-time
Years of relevant work:
14
Geographical preference:
Europe
Availability:
01 May 2026
Please log in to proceed